Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Integrating cannabis into clinical cancer care.

Abrams DI.

Curr Oncol. 2016 Mar;23(2):S8-S14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.

2.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

McAllister SD, Soroceanu L, Desprez PY.

J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28. Review.

3.

The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin.

Ju H, Lee S, Kang S, Kim SS, Ghil S.

Cell Commun Signal. 2014 Jul 10;12:39. doi: 10.1186/s12964-014-0039-9.

4.

Monoacylglycerol lipase - a target for drug development?

Fowler CJ.

Br J Pharmacol. 2012 Jul;166(5):1568-85. doi: 10.1111/j.1476-5381.2012.01950.x. Review.

5.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C, Liu Y, Debs RJ, Moore DH, Desprez PY.

Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. Erratum in: Breast Cancer Res Treat. 2012 May;133(1):401-4.

6.

Cannabinoids as novel anti-inflammatory drugs.

Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M.

Future Med Chem. 2009 Oct;1(7):1333-49. doi: 10.4155/fmc.09.93. Review.

7.
8.

The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

Supplemental Content

Support Center